Global Gamma Knife Market Expands as Demand for Non-Invasive Brain Tumor Treatment Rises The global Gamma Knife Market is experiencing steady growth as healthcare providers increasingly adopt advanced, non-invasive radiation therapies for treating neurological disorders and brain tumors. Valued at USD 234.28 million in 2024, the market is projected to reach nearly USD 313.3 million by 2032, growing at a CAGR of 3.7% during the forecast period from 2025 to 2032. Gamma Knife technology is a highly precise form of stereotactic radiosurgery designed primarily for treating tumors and abnormalities within the brain. Unlike traditional surgical procedures, Gamma Knife systems use concentrated beams of gamma radiation to target diseased tissues with exceptional accuracy while minimizing damage to surrounding healthy cells. The technology is widely used for treating malignant and benign brain tumors, trigeminal neuralgia, epilepsy, arteriovenous malformations (AVMs), and other neurological conditions. For further information, click the following link:https://www.maximizemarketresearch.com/request-sample/120871/
